Delivery Order SPE2DR25D1047-SPE2DR26F23U2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Qualipita 60 mg tablets (30-count packages) valued at $4,512.11 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of November 21, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Qualipita 60 mg tablets in a quantity of 30s, with a ceiling value of $2,022.06 under firm fixed price terms. This is a non-set-aside contract with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Qualipita 60 mg tablets (30-count) with a contract ceiling value of $5,737.27. This delivery order utilizes firm fixed pricing and was competitively awarded without set-aside designation. The contract is scheduled for completion by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,814.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This non-set-aside delivery order is scheduled for ultimate completion on November 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,372.53 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) under a firm fixed price contract valued at $4,640.36, with completion scheduled for December 1, 2025. This non-competitive, non-set-aside delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,551.70 by the Defense Logistics Agency on December 9, 2025, for the supply of Qualiptá 60 mg tablets in a quantity of 30 units. This firm fixed price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's Conshohocken facility. The award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count) under a firm fixed price contract. The order, valued at $13,271.90, was competitively awarded without set-aside provisions and carries an ultimate completion date of October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,337.55 to AmerisourceBergen Drug Corp for the supply of Qualiptа 30 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- SPE2DR25D1047Indefinite Delivery Contract
- SPE2DR25D1047-SPE2DR26F23U2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count) on December 3, 2025, with a ceiling value of $10,212.53. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a $999.9 million valuation through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for Department of Defense and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts covering a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders with firm fixed pricing demonstrates its capability to meet federal procurement requirements for pharmaceutical commodities supporting military and government healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 12/2/25 |